InvestWiser

EQL Pharma AB

EQLNasdaq StockholmHealthcareMarket value 657 m SEK
22.25SEK −8.1%
last day · Price as of 18 November 2026

The answer first

Does EQL Pharma beat the market?

No, EQL Pharma has not beaten the market over the last year.

EQL Pharma−55.7%Stockholm (OMXSGI)+18.7%
  • The ranking · Quality, value and trend combined

    Better than 10% of Nordic stocks

    • Quality20
    • Value35
    • Trend27

    No. 161 of 195 in healthcare

Max for seven days

Follow EQL Pharma with Aurora

Aurora lets you know at the next report. No card.

Both with dividends. Figures as of 18 November 2026. General analysis, not personal advice.

Follow your thesis

Follow your thesis on EQL Pharma

From today, at a price of 22.25 SEK. Write why you follow EQL Pharma, and choose what Aurora should tell you about.

What should Aurora follow?

Free, no card. The mission is ready when your account is.

Aurora tells you that something happened. What you do is your choice.

Ask Aurora about EQL Pharma

Your first answer is free, no account needed.

Do you own EQL Pharma, or are you thinking about it?

See it next to the rest of your portfolio, or build your first one with EQL Pharma and a few more. Free, no card.

Past year against the exchange and Super Stock
EQL Pharma−58.9%Stockholm (OMXSGI)+18.7%Super Stock+45.9%
14 November 202518 November 2026
All start at 0 % a year ago, with dividends. Super Stock is our model portfolio: the 20 highest-ranked Nordic stocks on quality, value and trend.

In short

  • EQL Pharma has fallen 55.7% over the past year, including dividends.
  • Overall, EQL Pharma ranks better than 10% of Nordic stocks on quality, value and trend.
  • The largest fall over the past three years was 82.4%. The price is 77.8% below its peak now.

What do analysts think of EQL Pharma?

Quality, value and trend

Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on.

10

Quality, value and trend together. Better than 10% of Nordic stocks.

No. 161 of 195 in healthcare

Quality20
The company · Fundamentals: the accounts

Low Weaker accounts than most: low profitability, high debt or uneven results.

No. 171 of 196 in healthcareTypical in healthcare: 64Typical in the Nordics: 50

  • Debt to equityBorrowings divided by equity1.33
  • Asset turnoverSales divided by everything the company owns0.62
  • Return on equityProfit divided by equity+0.4%
  • Cash conversionOperating cash flow divided by profit22.67

The ranking is built on equity ratio, ROA and how steadily profit grows.

Value35
The price · Valuation: the multiples

Medium Fair price: about the same as a typical Nordic stock.

No. 64 of 197 in healthcareTypical in healthcare: 21Typical in the Nordics: 50

  • P/BPrice divided by equity2.7
  • P/SPrice divided by sales1.4
  • P/EPrice divided by earnings638.9
  • P/CFPrice divided by operating cash flow28.2

The ranking is built on P/E, P/B and P/S.

Trend27
The share price · Technical: the price trend

Low Headwind in the share price: it has done worse than most over the last year.

No. 108 of 198 in healthcareTypical in healthcare: 34Typical in the Nordics: 50

  • 3 months−3.2%
  • 6 months−7.3%
  • 9 months−62.6%
  • 12 months−55.7%

The ranking is built on 3, 6 and 12–1 months.

Return and risk

1 month
+13.9%
3 years, per year
–
5 years, per year
–
Year to date
−58.1%
Largest fall, 3 years
−82.4%
From a peak to the bottom
From the peak now
−77.8%
How far the price is from the peak
Volatility, 1 year
65.4%
How much the price swings over a year
Beta, 1 year
1.02
How much the price moves when the market moves

Return with dividends reinvested.

The funds that own EQL Pharma

4 funds we follow own EQL Pharma. The share is how much of the fund the stock makes up.

  • Sweden4

From the funds' latest known holdings.

About EQL Pharma

EQL Pharma AB is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 65 employees.

EQL Pharma AB (publ) engages in the development, marketing, and sale of generic medicines to pharmacies and hospitals in Sweden, Denmark, Norway, Finland, and the rest of Europe. It offers prescription drugs, including hospital products. EQL Pharma AB (publ) was incorporated in 2006 and is headquartered in Lund, Sweden.

See the full analysis of EQL Pharma.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

Free forever · No card

Other healthcare stocks on Nasdaq Stockholm

Explore the stock market